back to top
HomeTagsMSIHigh

MSIHigh

IDEAYA Biosciences Broadcasts IND-Clearance for Werner Helicase Improvement Candidate IDE275 (GSK959) for a Part 1 Examine in MSI-Excessive Strong Tumors By Investing.com

IDE275 (GSK959) improvement is progressing into First-in-Human Part 1 medical trial(s) for the remedy of MSI-Excessive stable tumors, representing IDEAYA's 5th potential first-in-class medical...

Most Popular

spot_img